MapLight Therapeutics, Inc. (MPLT)

MapLight Therapeutics will go public soon, but the exact IPO date is still unknown.

Stock Price: Pending

IPO price not available yet

MapLight Therapeutics Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023
Selling, General & Admin	-	14.42	7.61
Research & Development	-	68.52	49.68
Operating Expenses	-	82.95	57.28
Operating Income	-97.88	-82.95	-57.28
Interest Expense / Income	-3.48	-4.5	-1.1
Other Expense / Income	-1.97	-0.86	-0.47
Pretax Income	-92.43	-77.58	-55.71
Net Income	-92.43	-77.58	-55.71
Free Cash Flow	-101.41	-79.59	-52.47
EBITDA	-96.74	-83.12	-56.25
Depreciation & Amortization	-0.84	-1.04	0.56
EBIT	-95.91	-82.08	-56.81

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).